Cadre (CDRE) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Apr, 2026Executive summary
Annual Meeting scheduled for May 29, 2026, via live webcast; shareholders can vote online or by proxy card.
Key proposals include electing five directors and ratifying KPMG LLP as independent auditor for 2026.
Shareholders of record as of April 7, 2026, are eligible to vote; each share equals one vote.
Proxy materials and annual report are available online; strong encouragement for advance voting.
Voting matters and shareholder proposals
Proposal 1: Elect five nominees to the Board of Directors for a one-year term.
Proposal 2: Ratify KPMG LLP as independent registered public accounting firm for 2026.
Shareholders may submit additional business or procedural matters at the meeting.
Plurality vote required for directors; majority for auditor ratification.
Shareholder proposals for 2027 must be submitted by December 25, 2026.
Board of directors and corporate governance
Board consists of five members, majority independent; Chairman is also CEO.
Board committees: Audit, Compensation, Nominating and Corporate Governance, each with independent members.
Lead independent director presides over executive sessions of independent directors.
Board held six meetings in 2025; all directors attended at least 75% of meetings.
Board reviews and maintains codes of ethics, governance guidelines, and committee charters.
Latest events from Cadre
- Strong Q2 2026 results and raised FY2026 outlook reflect robust growth and successful M&A.CDRE
Investor presentation - Q2 2026 net sales rose 32%, with record backlog and raised guidance on strong demand.CDRE
Q2 2026 - Record backlog and robust growth in safety and nuclear markets drive strong 2026 outlook.CDRE
Investor presentation - Supplement amends 2025 executive compensation details; all other proxy matters remain unchanged.CDRE
Proxy filing - Q1 2026 net sales up 19%, record backlog, and major acquisitions support strong outlook.CDRE
Q1 2026 - Strong FY2025 results and disciplined M&A fuel growth, with FY2026 sales guidance up to $758M.CDRE
Investor presentation - Record EBITDA and net income growth in 2025, with double-digit 2026 outlook and higher dividend.CDRE
Q4 2025 - Nuclear safety and engineered products drive growth, margin expansion, and resilience.CDRE
Investor Day 2025 - Apex armor and robotics launches showcase innovation and global expansion focus.CDRE
Investor Update